Physician

Horng-Chyi Richard Lai, MD

According to 2025 Medicare claims, Horng-Chyi Lai, MD (NPI: 1528385598) practices rheumatology in the Great Falls, MT market, with the plurality of this provider's patient population coming from Cascade, MT. This provider's primary affiliated billing organization is PURE INFUSION SUITES OF MONTANA LLC (NPI: 1588137228; TIN: 83-3021264) and primary practice location at 59405-5314. Lai is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and PRIVIA QUALITY NETWORK - I LLC (ACO ID: A5533), participating under the MSSP model.

Lai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 426 traditional Medicare patients, billed 180,753 HCPCS/CPT codes, and received $3,706,447 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,517 prescription claims across 322 beneficiaries totaling $3,344,562 in drug costs, led by Acthar (Corticotropin). 2016 DME data shows 11 claims. Open Payments data shows 236 records totaling $90,306. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,752 to $3,706,447. Similarly, Part D prescription costs have risen steadily, from $72,836 to $3,344,562. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.7M2015 Medicare payment: $4,752 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $67,206 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $83,839 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $84,046 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $91,383 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $86,944 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $929,590 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,280,227 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,343,711 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,706,447 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152460$4,752
20162021,080$67,206
20172901,284$83,839
20183471,384$84,046
20195541,880$91,383
20205251,559$86,944
202141548,047$929,590
2022411145,482$2,280,227
2023428159,497$3,343,711
2024426180,753$3,706,447

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.8M$5.5M2015 Drug cost: $72,836 (USD; Tot_Drug_Cst)2016 Drug cost: $349,179 (USD; Tot_Drug_Cst)2017 Drug cost: $658,008 (USD; Tot_Drug_Cst)2018 Drug cost: $1,201,195 (USD; Tot_Drug_Cst)2019 Drug cost: $3,483,280 (USD; Tot_Drug_Cst)2020 Drug cost: $5,507,754 (USD; Tot_Drug_Cst)2021 Drug cost: $4,310,214 (USD; Tot_Drug_Cst)2022 Drug cost: $2,580,050 (USD; Tot_Drug_Cst)2023 Drug cost: $2,098,304 (USD; Tot_Drug_Cst)2024 Drug cost: $3,344,562 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201553199$72,836
2016134727$349,179
20171981,250$658,008
20182691,727$1,201,195
20194613,907$3,483,280
20204564,165$5,507,754
20214333,125$4,310,214
20223572,661$2,580,050
20233572,512$2,098,304
20243222,517$3,344,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$404$8072016 Medicare payment: $807 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R11$807
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less145511$100
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more230525$89
96415Administration of chemotherapy into vein, each additional hour81375$21
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's223546$12
36415Insertion of needle into vein for collection of blood sample112263$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ActharCorticotropin13390$1,093,549
KevzaraSarilumab1032,898$441,118
Enbrel SureclickEtanercept441,456$376,733
Skyrizi PenRisankizumab-Rzaa181,236$363,586
RinvoqUpadacitinib361,260$268,538

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.235$83,034Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$7,272Amgen Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Horng-Chyi Richard Lai, MD?

Tedicare shows public-source Medicare data for Horng-Chyi Richard Lai, MD (NPI 1528385598), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Horng-Chyi Richard Lai, MD have ACO affiliation data?

Horng-Chyi Richard Lai, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and PRIVIA QUALITY NETWORK - I LLC (MSSP, ACO ID A5533).

What billing organization is linked to Horng-Chyi Richard Lai, MD?

Horng-Chyi Richard Lai, MD is linked to PURE INFUSION SUITES OF MONTANA LLC (billing NPI 1588137228) in the available physician profile data.

Does Horng-Chyi Richard Lai, MD have Open Payments data?

Horng-Chyi Richard Lai, MD has 236 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.